Biotech Hub

Pfizer Inc and Germany’s BioNTech SE said on Wednesday they will develop a potential mRNA-based vaccine for the prevention of viral infection shingles, collaborating for the third time after the…

This advertisement has not loaded yet, but your article continues below. Pfizer Inc and Germany’s BioNTech SE said on Wednesday they will develop a potential mRNA-based vaccine for the prevention of…

‘Global Drug Delivery Systems Market – Strategic recommendations, Trends, Segmentation, Use case Analysis, Competitive Intelligence, Global and Regional Forecast (to 2026)’ Global Drug Delivery…

Illumina will endeavor to integrate SomaLogic’s aptamer-based protein counting technology with its NGS and bioinformatics platforms by 2024.

All the big R&D trends are on display in this new, record-topping list of drug approvals for 2021. Plus one. Add up everything OK’d from CDER and CBER, and you have 61 new drug approvals for last…

A third former GlaxoSmithKline scientist caught in an alleged plot to steal trade secrets and sell the work in China pleaded guilty to conspiracy on Monday. Lucy Xi, a 44-year-old scientist, was…

Eisai’s metastatic breast cancer patient portrait campaign ‘This is MBC’ began seven years ago to bring metastatic cancer stories and conversations into the open. Its latest iteration with partner…

During a typically quiet holiday break in biotech, Piramal Pharma made some noise, and it’s starting off 2022 with yet another big announcement. The CDMO will invest millions into creating a high…

Is there a twindemic deja vu in the works? Although last year’s double whammy of Covid-19 and flu infections never panned out, CSL’s Seqirus wants to make sure it doesn’t happen this year, especially…

Still recovering from a setback in its lead program, Ovid Therapeutics has turned to AstraZeneca for a suite of experimental epilepsy drugs. Ovid is paying the Big Pharma partner $5 million in cash…